Clinical trial

Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia

NCT01121042

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-07-01

PhasePHASE3

Study timeline

Study start (unknown)2010-07-01Date precision: month

Registry last updated2020-10-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizoaffective and Schizophreniform Disordersunresolved

Schizophreniaunresolved

Interventions

OndansetronDRUG · verified · RxNorm: ondansetron

PlaceboDRUG

Sponsors & collaborators

Bayside Healthlead sponsor

Mapped research locations

MelbourneVictoria, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01121042 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.